Clinical trial
Voriconazole to Prevent Systemic Fungal Infections in Children
NCT00005912 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00005912 |
|---|---|
| Title | Voriconazole to Prevent Systemic Fungal Infections in Children |
| Official title | An Open Intravenous Multiple Dose, Multi-Center Study to Investigate the Pharmacokinetics, Safety and Toleration of Voriconazole in Children Aged 2-12 Years Who Require Treatment for the Prevention of Systemic Fungal Infection |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Aspergillosis, Candidiasis, Fungal Diseases, Mycoses |
| Intervention type | Drug |
| Interventions | Voriconazole |
| Enrollment | 48 |
| Start date | Jun 1, 2000 |
| Completion | Jan 1, 2001 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: